English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions Journal article
Li, Xiaocui, Ou, Xiaowen, Ni, Jiadong, Xu, Yihong, Zuo, Huilin, Fu, Yu, Yang, Caihua, Zhao, Zhongxiang, Li, Na, Zhou, Hua, Zhang, Rong, Liu, Zhongqiu, Fu, Ling, Zhu, Lijun. Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions[J]. Toxicology and Applied Pharmacology, 2022, 445.
Authors:  Li, Xiaocui;  Ou, Xiaowen;  Ni, Jiadong;  Xu, Yihong;  Zuo, Huilin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.3/3.6 | Submit date：2023/01/30
Adverse Reaction  Bulleyaconitine a  Cytochrome P450 Enzymes  Drug-drug Interactions  Human Liver Microsomes  Metabolism  
Comparison of risks for adverse drug reactions between traditional Chinese medicines and western medicines: A review of Chinese-language literatures Journal article
Song,Yan, Ruan,Zhen, Yin,Shi, Bian,Ying. Comparison of risks for adverse drug reactions between traditional Chinese medicines and western medicines: A review of Chinese-language literatures[J]. African Journal of Traditional, Complementary and Alternative Medicines, 2015, 12(5), 53-62.
Authors:  Song,Yan;  Ruan,Zhen;  Yin,Shi;  Bian,Ying
Favorite | TC[WOS]:2 TC[Scopus]:2 | Submit date：2021/03/01
Adverse Drug Reaction  Complementary Medicines  Drug Safety  Traditional Chinese Medicines  Western Medicines